Price $319.78 |
Market Cap
16.92B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
83.6
|
P/B
23.66
|
P/S
24.79
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
128.9
|
Op. Cash Flow
192.5K
|
FCF
2.9
|
|
Op. Margin
22.80%
|
Net Margin
16.30%
|
ROE
16.90%
|
ROI
18.90%
|
|
ROA
14.90%
|
EPS Growth
44.90%
|
Current Ratio
5.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Oncolytics Biotech, Inc. (USA) (ONCY) | $2.55 | - | - | 49.2M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.38 | - | - | 289.6M | Strong Buy |
| Altimmune Inc (ALT) | $3.20 | - | - | 16.5M | Strong Buy |
| Sangamo Therapeutics Inc (SGMO) | $11.21 | - | - | 1.42B | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.73 | - | - | 146.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
